Thermoresponsive hydrogels as a new ocular drug delivery platform to the posterior segment of the eye

Transactions of the American Ophthalmological Society

Volumn 106, Issue , 2008, Pages 206-213

  Kang Derwent, Jennifer J ^a   Mieler, William F ^b  

^a Illinois Institute of Technology   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BOVINE SERUM ALBUMIN; IMMUNOGLOBULIN G; MACROGOL DERIVATIVE; POLY(ETHYLENE GLYCOL)DIACRYLATE; POLY(N ISOPROPYLACRYLAMIDE); RANIBIZUMAB; UNCLASSIFIED DRUG; ACRYLAMIDE DERIVATIVE; ANGIOGENESIS INHIBITOR; FLUORESCEIN ISOTHIOCYANATE; MONOCLONAL ANTIBODY; POLY(N-ISOPROPYLACRYLAMIDE); POLYMER; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG RELEASE; HISTOLOGY; HUMAN; HUMAN CELL; HYDROGEL; IN VITRO STUDY; NONHUMAN; PHASE TRANSITION; POSTERIOR EYE CHAMBER; PRIORITY JOURNAL; RAT; ROOM TEMPERATURE; TEMPERATURE SENSITIVITY; ANIMAL; BIOAVAILABILITY; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; LONG EVANS RAT; METABOLISM; RETINA; TEMPERATURE; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ACRYLAMIDES; ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODIES, MONOCLONAL; BIOLOGICAL AVAILABILITY; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, VASCULAR; FLUORESCEIN-5-ISOTHIOCYANATE; HYDROGELS; IMMUNOGLOBULIN G; POLYETHYLENE GLYCOLS; POLYMERS; RATS; RATS, LONG-EVANS; RETINA; SERUM ALBUMIN, BOVINE; TEMPERATURE; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 63049131601     PISSN: None     EISSN: 15456110     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
2. Leung D, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246;1306-1309.
3. Keck P, Hauser SD, Krivi G, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989;246:1309-1312.
4. Aiello L, Avery R., Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-1487.
5. Kvanta A, Algvere PV, Berglin L, et al. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci 1996;37,1929-1934.
6. Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev 2002;54:3-12.
7. Kim SW, Bae YH, Okano T. Hydrogels: swelling, drug loading, and release. Pharm Res 1962;9:283-290.
8. Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chem Rev 2001;101:1869-1880.
9. Heskin M, Guillet JE. Solution properties of poly(N-isopropylacrylamide). J Macromol Sci 1968;2:1441-1455.
10. Dhara D, Chatterji PR. Phase transition in linear and cross-linked poly(N-isopropylacrylamide) in water: effect of various types of additives. J Macromol Sci Rev Macromol Chem Phys 2000;C40:51-68.
11. Bae YH, Okano R, Hsu S, Kim W. Thermo-sensitive polymers as on-off switches for drug release. Makromol Chem Rapid Commun 1987;8:481-485.
12. Zhang XZ, Yang YY, Chung TS, Ma KX. Fabrication and characterization of fast response poly(N-isopropylacrylamide) hydrogels. Langmuir 2001;17:6094-6099.
13. Zhuo RX, Li W. Preparation and characterization of macroporous release of proteins. J Polymer Sci Polymer Chem 2003;41:152-159.
14. Pratt AB, Weber FE, Schmoekel HG, Mueller R, Hubbell JA. Synthetic extracellular matrices for in situ tissue engineering. Biotechnol Bioeng 2004;86:27-36.
15. Raeber GP, Lutolf MP, Hubbell JA. Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration. Biophys J 2005;89:1374-1388.
16. Zhang XZ, Chu CC. Fabrication and characterization of microgel-impregnated, thermosensitive PNIPAAm hydrogels. Polymer 2005;46:9664-9673.
17. Yamaoka T, Tabata Y, Ikada Y. Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice. J Pharm Sci 1994;83:601-606.
18. Allmer K, Hilborn J, Larsson PH, Hult A. Surface modification of polymers. V. Biomaterial applications. J Polymer Sci Polymer Chem 1990;28:173-183.
19. Desai NP, Hubbell JA. Biological responses to polyethylene oxide modified polyethylene terephthalate surfaces. J Biomed Mater Res 1991;25:829-843.
20. Fuerteges F, Abuchowski A. The clinical efficacy of poly(ethylene glycol)-modified proteins. J Control Release 1990;11:139-148.
21. Yokoyama M, Okano R, Sakurai Y, Ekimoto H, Shibazaki C, Kataoka K. Toxicity and antitumor-activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res 1991;51:3229-3236.
22. Valdes-Aguilera O, Pathak CP, Shi J, Watson D, Neckers DC. Photopolymerization studies using visible light photoinitiators. Macromolecules 1992;25:541-547.
23. Weir MD, Antonucci JM, Wang FW. Rapid screening of the lower critical solution temperature of injectable hydrogels for tissue engineering applications [abstract]. Trans Soc Biomater 2002.
24. Hashimoto K, Sakamoto J, Tanji H. Neurotoxicity of arcylamide and related compounds and their effects on male gonads in mice. Arch Toxicol 1981;47:179-189.
25. Takezawa T, Mori Y, Yoshizato K. Cell culture on a thermo-responsive polymer surface. BioTechnology (N Y) 1990;8:854-856.
26. Malonne H, Eeckman F, Fontaine D, et al. Preparation of poly(N-isopropylacrylamide) copolymers and preliminary assessment of their acute and subactue toxicity in mice. Eur J Pharm Biopharm 2005;61:188-194.
27. Ghate D, Edelhause HF. Ocular drug delivery. Expert Opin Drug Deliv 2006;3:275-287.
28. Yasukawa T, Ogura Y, Kimura H, Sakurai E, Tabata Y. Drug delivery from ocular implants. Expert Opin Drug Deliv 2006;3:261-273.